0001179110-20-006035.txt : 20200514 0001179110-20-006035.hdr.sgml : 20200514 20200514175246 ACCESSION NUMBER: 0001179110-20-006035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200512 FILED AS OF DATE: 20200514 DATE AS OF CHANGE: 20200514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheena Jonathan CENTRAL INDEX KEY: 0001646649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 20879476 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 edgar.xml FORM 4 - X0306 4 2020-05-12 0 0001604821 Natera, Inc. NTRA 0001646649 Sheena Jonathan C/O NATERA, INC., 201 INDUSTRIAL ROAD SUITE 410 SAN CARLOS CA 94070 1 1 0 0 Chief Technology Officer Common Stock 2020-05-12 4 M 0 3034 9.59 A 249969 D Common Stock 2020-05-12 4 S 0 3034 49.052 D 246935 D Common Stock 2020-05-12 4 M 0 4851 10.41 A 251786 D Common Stock 2020-05-12 4 S 0 4851 49.046 D 246935 D Stock Option (right to buy) 9.59 2020-05-12 4 M 0 3034 0 D 2026-04-07 Common Stock 3034 69614 D Stock Option (right to buy) 10.41 2020-05-12 4 M 0 4851 0 D 2027-06-08 Common Stock 4851 102399 D The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2019. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.01 to $49.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.22 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares vested fully and became exercisable on April 1, 2020. The option shares vest over four years. 25% of the option shares vest and become exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Tami Chen, attorney-in-fact 2020-05-14